Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

NCT00889525 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Cushing's Disease
Corticotroph Adenoma

Interventions

DRUG: Cabergoline

Sponsor

Seth Gordhandas Sunderdas Medical College